# Lidocaine Versus Bupivacaine for Sphenopalatine Ganglion Block

> **NCT05269147** · NA · COMPLETED · sponsor: **Huda Fahmy Mahmoud, PhD** · enrollment: 60 (actual)

## Conditions studied

- Septum; Deviation, Congenital

## Interventions

- **PROCEDURE:** Sphenopalatine Ganglion Block (SPGB)

## Key facts

- **NCT ID:** NCT05269147
- **Lead sponsor:** Huda Fahmy Mahmoud, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05269147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05269147, "Lidocaine Versus Bupivacaine for Sphenopalatine Ganglion Block". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05269147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*